2-propanol and latanoprost

2-propanol has been researched along with latanoprost in 56 studies

Research

Studies (56)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	12 (21.43)	18.2507
2000's	39 (69.64)	29.6817
2010's	4 (7.14)	24.3611
2020's	1 (1.79)	2.80

Authors

Authors	Studies
Resul, B; Selén, G; Sjöquist, B; Stjernschantz, J	1
Abdel-Latif, AA; Ye, Z; Yousufzai, SY	1
Albert, DM; Imesch, PD; Wallow, IH	1
Resul, B; Selén, G; Stjernschantz, J	1
Olsson, K; Stjernschantz, J; Wistrand, PJ	1
Bito, LZ; Camras, CB; Toris, CB; Wang, YL; Zhan, GL	1
Higginbotham, EJ; Pappas, RM; Pusin, S	1
Abdel-Latif, AA; Yousufzai, SY	1
Buckley, EG; Enyedi, LB; Freedman, SF	1
Albert, DM; Grierson, I; Lee, WR	1
Camras, CB; Eisenberg, DL	1
Larsson, BS; Lindquist, NG; Stjernschantz, J	1
Chen, YF; Hsieh, JW; Hung, PT; Wei, T	1
Camras, CB; Neely, DG; Weiss, EL	1
Napolitano, A; Prota, G; Selen, G; Stjernschantz, J; Vincensi, MR	1
Cunningham, ET; Gaynor, BD; Stamper, RL	1
Hu, DN; Lake, S; Ocklind, A; Stjernschantz, J; Wentzel, P	1
Appleton, P; Goldsmith, H; Grierson, I; Hochgesand, D; Pfeiffer, N; Winkgen-Böhres, A	1
Angert, M; Hewitt, EG; Jones, HL; Lindsey, JD; Weinreb, RN	1
Hara, T	1
Angert, M; Lindsey, JD; Wang, N; Weinreb, RN	1
Andrew, R; Bergamini, MV; Davis, AA; Dickerson, J; Landry, T; Mallick, S; Netland, PA; Robertson, SM; Silver, L; Sullivan, EK; Weiner, A	1
Abe, K; Chiba, T; Furuichi, M; Iijima, H; Kashiwagi, K; Kogure, S; Shibuya, T; Tsukahara, S	1
Haik, BG; McLean, IW; Sivak-Callcott, JA; Tsai, JC; Zhang, J	1
Hara, T; Inagaki, Y; Kumagai, K; Otaka, I; Saegusa, K; Shimoyama, M	1
Iizuka, Y; Kanai, N; Kashiwagi, K; Suzuki, M; Tanaka, Y; Tsuchida, T; Tsukahara, S	1
Cheng, CY; Chiang, SC; Chiu, AW; Chou, JC; Hsu, WM; Liu, CJ; Liu, JH	1
Albert, DM; Drago, F; Hu, DN; Stjernschantz, JW; Wistrand, PJ	1
Appleton, P; Cracknell, KP; Grierson, I; Pfeiffer, N	1
Arranz-Márquez, E; Lucea-Suescun, P; Teus, MA	1
Bergh, K; Stjernschantz, J; Wentzel, P	1
Bergh, K; Niemelä, P; Stjernschantz, J; Wallin, O; Wentzel, P	1
Appleton, P; Goldsmith, H; Grierson, I; Hochgesand, D; Pfeiffer, N; Winkgen, A	1
Abdel-Latif, AA; Ansari, HR; Davis, AM; Kaddour-Djebbar, I	1
Tesser, PM	1
Fröhlich, SJ; Kampik, A; Mueller, AJ	1
Appleton, P; Cracknell, KP; Grierson, I; Hogg, P; Pfeiffer, N	1
Goto, W; Hara, H; Kageyama, M; Matsugi, T; Matsumura, Y; Mori, N; Nakajima, T	1
Abdel-Latif, AA; Ansari, HR; Kaddour-Djebbar, I	1
Alm, A; McDermott, J; Schoenfelder, J	1
Arranz-Marquez, E; Gil, R; Mendez, MC; Saornil, MA; Teus, MA	1
Albert, DM; Damico, CM; Fisher, MR; Gangnon, RE; Gleiser, J; Green, WR; Grossniklaus, HE; Zimbric, ML	1
Abdel-Latif, AA; Akhtar, RA; Ansari, HR; Kaddour-Djebbar, I	1
Iveković, R; Korsić, J; Mandić, Z; Masnec-Paskvalin, S; Novak-Laus, K; Zorić-Geber, M	1
Hara, T; Inoue, J; Inoue, K; Matsuo, H; Tomita, G; Wakakura, M	1
Hasegawa, Y; Hirano, K; Ishibashi, T; Kanaide, H; Niiro, N; Nishimura, J	1
Cracknell, KP; Grierson, I; Hogg, P	1
Cracknell, KP; Farnell, DJ; Grierson, I	1
Arranz-Marquez, E; Teus, MA	1
Martin, J; Schwartz, B; Takamoto, T	1
Albert, DM; Darjatmoko, S; Gangnon, RE; Green, WR; Grossniklaus, HE; Kulkarni, AD	1
Baycu, C; Kara, S; Sahin, A; Yildirim, N	1
Sihota, R	1
Borghi, V; Carreiro, ST; Chiroli, V; Chong, WK; Gale, DC; Impagnatiello, F; Krauss, AH; Ongini, E; Prasanna, G; Toris, CB	1
Anderson, MG; Dutca, LM; Galor, A; Garvin, MK; Robles, V; Rudd, D	1
Agarwal, P; Goldsmith, JA; Sayegh, RR; Smith, SD	1

Reviews

5 review(s) available for 2-propanol and latanoprost

Article	Year
The color of the human eye: a review of morphologic correlates and of some conditions that affect iridial pigmentation. Survey of ophthalmology, 1997, Volume: 41 Suppl 2 Topics: Cell Count; Cell Division; Eye Color; Humans; Iris; Iris Diseases; Latanoprost; Melanins; Pigment Epithelium of Eye; Pigmentation Disorders; Prostaglandins F, Synthetic	1997
A preliminary risk-benefit assessment of latanoprost and unoprostone in open-angle glaucoma and ocular hypertension. Drug safety, 1999, Volume: 20, Issue:6 Topics: Dinoprost; Drug Administration Schedule; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Iris; Latanoprost; Ocular Hypertension; Pigment Epithelium of Eye; Prostaglandins F, Synthetic; Risk Assessment	1999
Mechanism and clinical significance of prostaglandin-induced iris pigmentation. Survey of ophthalmology, 2002, Volume: 47 Suppl 1 Topics: Amides; Animals; Antihypertensive Agents; Bimatoprost; Cloprostenol; Dinoprost; Eye Color; Gene Expression Regulation; Humans; Iris; Iris Diseases; Latanoprost; Lipids; Melanocytes; Monophenol Monooxygenase; Pigmentation Disorders; Prostaglandins F, Synthetic; Receptors, Prostaglandin; Travoprost; Up-Regulation	2002
Histology and fine structure of the iris and outflow system following latanoprost therapy. Survey of ophthalmology, 2002, Volume: 47 Suppl 1 Topics: Antihypertensive Agents; Eye Color; Glaucoma; Humans; Intraocular Pressure; Iris; Iris Diseases; Latanoprost; Melanins; Melanocytes; Pigmentation Disorders; Prostaglandins F, Synthetic; Trabecular Meshwork	2002
An Indian perspective on primary angle closure and glaucoma. Indian journal of ophthalmology, 2011, Volume: 59 Suppl Topics: Acute Disease; Anterior Chamber; Antihypertensive Agents; Chronic Disease; Cornea; Disease Progression; Drug Administration Schedule; Glaucoma, Angle-Closure; Humans; Incidence; India; Iris; Latanoprost; Ocular Hypertension; Ophthalmologic Surgical Procedures; Prevalence; Prostaglandins F, Synthetic; Timolol	2011

Trials

11 trial(s) available for 2-propanol and latanoprost

Article	Year
The incidence and time-course of latanoprost-induced iridial pigmentation as a function of eye color. Survey of ophthalmology, 1997, Volume: 41 Suppl 2 Topics: Adrenergic beta-Antagonists; Double-Blind Method; Europe; Eye Color; Glaucoma; Humans; Incidence; Intraocular Pressure; Iris; Iris Diseases; Latanoprost; Melanins; Melanosis; Ophthalmic Solutions; Prostaglandins F, Synthetic; Time Factors; Timolol; United States	1997
The effectiveness of latanoprost for the treatment of pediatric glaucoma. Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus, 1999, Volume: 3, Issue:1 Topics: Adolescent; Child; Child, Preschool; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Infant; Intraocular Pressure; Iris; Latanoprost; Male; Ophthalmic Solutions; Pigment Epithelium of Eye; Prospective Studies; Prostaglandins F, Synthetic; Safety; Treatment Outcome	1999
The fine structure of an iridectomy specimen from a patient with latanoprost-induced eye color change. Archives of ophthalmology (Chicago, Ill. : 1960), 1999, Volume: 117, Issue:3 Topics: Aged; Cataract Extraction; Eye Color; Female; Humans; Intraocular Pressure; Iris; Iris Diseases; Latanoprost; Ocular Hypertension; Ophthalmic Solutions; Pigmentation Disorders; Prostaglandins F, Synthetic	1999
Histological effects in the iris after 3 months of latanoprost therapy: the Mainz 1 study. Archives of ophthalmology (Chicago, Ill. : 1960), 2001, Volume: 119, Issue:2 Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Biomarkers; Exfoliation Syndrome; Female; Glaucoma, Open-Angle; Humans; Immunoenzyme Techniques; Intraocular Pressure; Iris; Ki-67 Antigen; Latanoprost; Male; Middle Aged; Ophthalmic Solutions; Proliferating Cell Nuclear Antigen; Prostaglandins F, Synthetic; Single-Blind Method; Trabeculectomy	2001
Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension. American journal of ophthalmology, 2001, Volume: 132, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Cloprostenol; Double-Blind Method; Eye Color; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Iris; Latanoprost; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Pigmentation Disorders; Prodrugs; Prostaglandins F, Synthetic; Safety; Timolol; Travoprost; Treatment Outcome	2001
Iridial pigmentation induced by latanoprost ophthalmic solution in Japanese glaucoma patients. Journal of glaucoma, 2001, Volume: 10, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Eye Color; Female; Glaucoma; Humans; Incidence; Intraocular Pressure; Iris; Iris Diseases; Japan; Latanoprost; Male; Melanosis; Middle Aged; Ophthalmic Solutions; Prospective Studies; Prostaglandins F, Synthetic	2001
Use of latanoprost to reduce acute intraocular pressure rise following neodymium: Yag laser iridotomy. Acta ophthalmologica Scandinavica, 2002, Volume: 80, Issue:3 Topics: Acute Disease; Aged; Aged, 80 and over; Antihypertensive Agents; Female; Glaucoma, Angle-Closure; Humans; Intraocular Pressure; Iris; Laser Therapy; Latanoprost; Male; Middle Aged; Ocular Hypertension; Pilocarpine; Premedication; Prostaglandins F, Synthetic; Safety; Tonometry, Ocular; Treatment Outcome; Visual Acuity	2002
Fine structural evaluation of the iris after unilateral treatment with latanoprost in patients undergoing bilateral trabeculectomy (the Mainz II study). Archives of ophthalmology (Chicago, Ill. : 1960), 2003, Volume: 121, Issue:1 Topics: Administration, Topical; Aged; Antihypertensive Agents; Double-Blind Method; Exfoliation Syndrome; Female; Glaucoma, Open-Angle; Humans; Iris; Latanoprost; Male; Melanins; Melanocytes; Middle Aged; Prostaglandins F, Synthetic; Trabeculectomy	2003
A 5-year, multicenter, open-label, safety study of adjunctive latanoprost therapy for glaucoma. Archives of ophthalmology (Chicago, Ill. : 1960), 2004, Volume: 122, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Chemotherapy, Adjuvant; Drug Evaluation; Exfoliation Syndrome; Eye Color; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Iris; Latanoprost; Longitudinal Studies; Male; Middle Aged; Ophthalmic Solutions; Pigmentation Disorders; Prospective Studies; Prostaglandins F, Synthetic; Safety	2004
[Use of antiglaucoma therapy to reduce acute intraocular pressure rise following neodymium: YAG laser iridotomy in angle-closure glaucoma patients]. Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti, 2006, Volume: 60, Issue:2 Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Brimonidine Tartrate; Drug Therapy, Combination; Female; Glaucoma, Angle-Closure; Humans; Iris; Laser Therapy; Latanoprost; Male; Middle Aged; Miotics; Ocular Hypertension; Pilocarpine; Postoperative Complications; Prostaglandins F, Synthetic; Quinoxalines	2006
Increase and decrease of measurements of iris density of glaucoma patients treated with latanoprost over 36 months. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2008, Volume: 24, Issue:1 Topics: Aged; Female; Follow-Up Studies; Glaucoma; Humans; Image Processing, Computer-Assisted; Iris; Latanoprost; Male; Middle Aged; Multivariate Analysis; Neuroprotective Agents; Prospective Studies; Prostaglandins F, Synthetic	2008

Other Studies

40 other study(ies) available for 2-propanol and latanoprost

Article	Year
Preclinical pharmacology of latanoprost, a phenyl-substituted PGF2 alpha analogue. Advances in prostaglandin, thromboxane, and leukotriene research, 1995, Volume: 23 Topics: Administration, Topical; Animals; Aqueous Humor; Blood Platelets; Cats; Cattle; Cornea; Coronary Vessels; Corpus Luteum; Dinoprost; Female; Guinea Pigs; Ileum; In Vitro Techniques; Iris; Latanoprost; Macaca fascicularis; Male; Muscle, Smooth; Organ Specificity; Prostaglandins F, Synthetic; Rabbits; Regional Blood Flow; Swine; Vas Deferens	1995
Prostaglandin F2 alpha and its analogs induce release of endogenous prostaglandins in iris and ciliary muscles isolated from cat and other mammalian species. Experimental eye research, 1996, Volume: 63, Issue:3 Topics: Animals; Cats; Cattle; Ciliary Body; Cyclooxygenase Inhibitors; Dexamethasone; Dinoprost; Dinoprostone; Dogs; Dose-Response Relationship, Drug; Humans; Indomethacin; Iris; Latanoprost; Macaca mulatta; Muscles; Prostaglandins; Prostaglandins F, Synthetic; Rabbits	1996
Prostaglandin-induced iridial pigmentation in primates. Survey of ophthalmology, 1997, Volume: 41 Suppl 2 Topics: Administration, Topical; Animals; Dinoprost; Dinoprostone; Eye Color; Iris; Iris Diseases; Latanoprost; Macaca fascicularis; Melanosis; Ophthalmic Solutions; Pigment Epithelium of Eye; Prostaglandins; Prostaglandins F, Synthetic; Sympathectomy	1997
Prostaglandin-induced iris color darkening. An experimental model. Archives of ophthalmology (Chicago, Ill. : 1960), 1998, Volume: 116, Issue:8 Topics: Administration, Topical; Animals; Eye Color; Female; Ganglia, Sympathetic; Ganglionectomy; Hyperpigmentation; Iris; Latanoprost; Models, Biological; Ophthalmic Solutions; Photography; Prostaglandins F, Synthetic; Rabbits	1998
Evidence of early change in iris color with latanoprost use. Archives of ophthalmology (Chicago, Ill. : 1960), 1998, Volume: 116, Issue:8 Topics: Aged; Eye Color; Female; Humans; Intraocular Pressure; Iris; Iris Diseases; Latanoprost; Ocular Hypertension; Pigmentation Disorders; Prostaglandins F, Synthetic	1998
Tyrosine kinase inhibitors suppress prostaglandin F2alpha-induced phosphoinositide hydrolysis, Ca2+ elevation and contraction in iris sphincter smooth muscle. European journal of pharmacology, 1998, Nov-06, Volume: 360, Issue:2-3 Topics: Animals; Calcium; Carbachol; Cardiotonic Agents; Cats; Dinoprost; Dose-Response Relationship, Drug; Enzyme Inhibitors; Genistein; Hydrolysis; Iris; Latanoprost; Muscle Contraction; Muscle, Smooth; Phosphatidylinositols; Prostaglandins F, Synthetic; Protein-Tyrosine Kinases; Vanadates	1998
Increased pigmentation of iridial melanocytes in primates induced by a prostaglandin analogue. Experimental eye research, 1999, Volume: 69, Issue:4 Topics: Animals; Eye Color; Female; Iris; Latanoprost; Macaca fascicularis; Male; Melanins; Melanocytes; Methimazole; Prostaglandins F, Synthetic	1999
Efficacy of latanoprost as an adjunct to medical therapy for residual angle-closure glaucoma after iridectomy. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2000, Volume: 16, Issue:1 Topics: Adjuvants, Pharmaceutic; Aged; Antihypertensive Agents; Female; Glaucoma, Angle-Closure; Humans; Iris; Latanoprost; Male; Middle Aged; Prostaglandins F, Synthetic; Time Factors	2000
Latanoprost-induced iris color darkening: a case report with long-term follow-up. Journal of glaucoma, 2000, Volume: 9, Issue:1 Topics: Antihypertensive Agents; Autonomic Nervous System Diseases; Cocaine; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Iris; Iris Diseases; Latanoprost; Male; Middle Aged; Ophthalmic Solutions; Pigmentation Disorders; Prostaglandins F, Synthetic; Pupil; Sympathetic Nervous System	2000
Latanoprost stimulates eumelanogenesis in iridial melanocytes of cynomolgus monkeys. Pigment cell research, 2000, Volume: 13, Issue:3 Topics: Administration, Topical; Animals; Antihypertensive Agents; Female; Hyperpigmentation; Iris; Iris Diseases; Latanoprost; Macaca fascicularis; Melanins; Melanocytes; Monophenol Monooxygenase; Ophthalmic Solutions; Prostaglandins F, Synthetic	2000
Presumed activation of herpetic keratouveitis after Argon laser peripheral iridotomy. American journal of ophthalmology, 2000, Volume: 130, Issue:5 Topics: Acyclovir; Aged; Antiviral Agents; Chronic Disease; Glaucoma; Herpesvirus 1, Human; Humans; Intraocular Pressure; Iris; Keratitis, Herpetic; Laser Therapy; Latanoprost; Male; Prostaglandins F, Synthetic; Uveitis, Anterior; Virus Activation	2000
Latanoprost-induced increase of tyrosinase transcription in iridial melanocytes. Acta ophthalmologica Scandinavica, 2000, Volume: 78, Issue:6 Topics: Animals; Antihypertensive Agents; Blotting, Northern; Choroid; Female; In Situ Hybridization; Iris; Latanoprost; Macaca fascicularis; Male; Melanocytes; Monophenol Monooxygenase; Pigment Epithelium of Eye; Prostaglandins F, Synthetic; RNA, Messenger; Transcription, Genetic	2000
Induction of tyrosinase gene transcription in human iris organ cultures exposed to latanoprost. Archives of ophthalmology (Chicago, Ill. : 1960), 2001, Volume: 119, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; DNA Primers; DNA Probes; Enzyme Induction; Eye Color; Glyceraldehyde-3-Phosphate Dehydrogenases; Humans; Iris; Latanoprost; Middle Aged; Monophenol Monooxygenase; Organ Culture Techniques; Polymerase Chain Reaction; Prostaglandins F, Synthetic; RNA, Messenger; Tissue Donors; Transcription, Genetic	2001
[Increased iris pigmentation after use of latanoprost in Japanese brown eyes]. Nippon Ganka Gakkai zasshi, 2001, Volume: 105, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Eye Color; Female; Glaucoma; Humans; Iris; Latanoprost; Male; Middle Aged; Ophthalmic Solutions; Pigmentation Disorders; Prostaglandins F, Synthetic	2001
Latanoprost and matrix metalloproteinase-1 in human choroid organ cultures. Current eye research, 2001, Volume: 22, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Blotting, Western; Choroid; Ciliary Body; Dinoprost; DNA Primers; DNA Probes; Humans; Immunoblotting; Iris; Latanoprost; Matrix Metalloproteinase 1; Middle Aged; Organ Culture Techniques; Polymerase Chain Reaction; Prostaglandins F, Synthetic; RNA, Messenger	2001
Latanoprost-induced iris heterochromia and open-angle glaucoma: a clinicopathologic report. Journal of glaucoma, 2001, Volume: 10, Issue:5 Topics: Antihypertensive Agents; Diagnosis, Differential; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Iris; Iris Diseases; Latanoprost; Melanosis; Middle Aged; Mitomycin; Prostaglandins F, Synthetic; Trabeculectomy	2001
Simple and inexpensive software designed for the evaluation of color. American journal of ophthalmology, 2002, Volume: 133, Issue:1 Topics: Antihypertensive Agents; Eye Color; Humans; Iris; Iris Diseases; Latanoprost; Pigmentation Disorders; Prostaglandins F, Synthetic; Software Design	2002
Comparison between isopropyl unoprostone and latanoprost by prostaglandin E(2)induction, affinity to prostaglandin transporter, and intraocular metabolism. Experimental eye research, 2002, Volume: 74, Issue:1 Topics: Adult; Animals; Antihypertensive Agents; Antiporters; Aqueous Humor; Cattle; Culture Techniques; Cyclooxygenase Inhibitors; Dinoprost; Dinoprostone; DNA-Binding Proteins; HeLa Cells; Humans; Indomethacin; Iris; Latanoprost; Organic Anion Transporters; Prostaglandins F, Synthetic	2002
Incidence of iris colour change in latanoprost treated eyes. The British journal of ophthalmology, 2002, Volume: 86, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Cohort Studies; Erythrocytes; Eye Color; Female; Glaucoma; Humans; Iris; Latanoprost; Male; Middle Aged; Photography; Prospective Studies; Prostaglandins F, Synthetic	2002
Production of prostaglandin e(2) by iridial melanocytes exposed to latanoprost acid, a prostaglandin F(2 alpha) analogue. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2002, Volume: 18, Issue:5 Topics: Aged; Aged, 80 and over; Animals; Cattle; Cells, Cultured; Dinoprostone; Female; Humans; Iris; Latanoprost; Male; Melanocytes; Middle Aged; Pigment Epithelium of Eye; Prostaglandins F, Synthetic; Thromboxane B2; Trabeculectomy	2002
Transcription of prostanoid receptor genes and cyclooxygenase enzyme genes in cultivated human iridial melanocytes from eyes of different colours. Pigment cell research, 2003, Volume: 16, Issue:1 Topics: Aged; Aged, 80 and over; Cells, Cultured; Cyclooxygenase 1; Cyclooxygenase 2; Eye Color; Female; Humans; Iris; Isoenzymes; Latanoprost; Male; Melanocytes; Membrane Proteins; Middle Aged; Prostaglandin-Endoperoxide Synthases; Prostaglandins F, Synthetic; Receptors, Prostaglandin; Transcription, Genetic	2003
Effects of prostaglandin F2alpha and latanoprost on phosphoinositide turnover, myosin light chain phosphorylation and contraction in cat iris sphincter. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2003, Volume: 19, Issue:3 Topics: Animals; Antihypertensive Agents; Cats; Dinoprost; Dose-Response Relationship, Drug; In Vitro Techniques; Intraocular Pressure; Iris; Latanoprost; Muscle Contraction; Muscle, Smooth; Myosin Light Chains; Myosin-Light-Chain Kinase; Phosphatidylinositols; Phosphorylation; Prostaglandins F, Synthetic	2003
An iris coloboma preventing pigmentary glaucoma. Archives of ophthalmology (Chicago, Ill. : 1960), 2003, Volume: 121, Issue:7 Topics: Coloboma; Exfoliation Syndrome; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Iris; Laser Therapy; Latanoprost; Male; Middle Aged; Prostaglandins F, Synthetic; Trabeculectomy	2003
[Relative contraindication of latanoprost in iris tumors with secondary glaucoma]. Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2003, Volume: 100, Issue:8 Topics: Adult; Antihypertensive Agents; Cell Transformation, Neoplastic; Contraindications; Disease Progression; Glaucoma; Humans; Intraocular Pressure; Iris; Iris Neoplasms; Latanoprost; Male; Melanoma; Prostaglandins F, Synthetic	2003
Latanoprost-induced iris darkening: a morphometric study of human peripheral iridectomies. Experimental eye research, 2003, Volume: 77, Issue:6 Topics: Antihypertensive Agents; Exfoliation Syndrome; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Iridectomy; Iris; Iris Diseases; Latanoprost; Melanins; Melanocytes; Melanosomes; Microscopy, Electron; Pigmentation Disorders; Prostaglandins F, Synthetic; Stromal Cells; Trabeculectomy	2003
New fluoroprostaglandin F(2alpha) derivatives with prostanoid FP-receptor agonistic activity as potent ocular-hypotensive agents. Biological & pharmaceutical bulletin, 2003, Volume: 26, Issue:12 Topics: Administration, Topical; Animals; Cats; Cell Line, Tumor; Dinoprost; Drug Evaluation, Preclinical; Forecasting; Intraocular Pressure; Iris; Latanoprost; Macaca fascicularis; Melanins; Mice; Miosis; Prostaglandins F; Prostaglandins F, Synthetic; Receptors, Prostaglandin	2003
Effects of prostaglandin F2alpha, latanoprost and carbachol on phosphoinositide turnover, MAP kinases, myosin light chain phosphorylation and contraction and functional existence and expression of FP receptors in bovine iris sphincter. Experimental eye research, 2004, Volume: 78, Issue:2 Topics: Animals; Antihypertensive Agents; Carbachol; Cattle; Culture Techniques; Dinoprost; Dose-Response Relationship, Drug; Inositol Phosphates; Iris; Latanoprost; Mitogen-Activated Protein Kinases; Muscle Contraction; Muscle, Smooth; Myosin Light Chains; Phosphatidylinositols; Phosphorylation; Prostaglandins F, Synthetic; Receptors, Prostaglandin; Signal Transduction	2004
Analysis of irises with a latanoprost-induced change in iris color. American journal of ophthalmology, 2004, Volume: 138, Issue:4 Topics: Aged; Antihypertensive Agents; Biopsy; Exfoliation Syndrome; Eye Color; Female; Glaucoma, Open-Angle; Humans; Inclusion Bodies; Iris; Iris Diseases; Latanoprost; Male; Melanins; Melanocytes; Melanosis; Middle Aged; Prospective Studies; Prostaglandins F, Synthetic	2004
A study of iridectomy histopathologic features of latanoprost- and non-latanoprost-treated patients. Archives of ophthalmology (Chicago, Ill. : 1960), 2004, Volume: 122, Issue:11 Topics: Antihypertensive Agents; Eye Color; Female; Glaucoma; Humans; Intraocular Pressure; Iridectomy; Iris; Latanoprost; Male; Melanins; Melanocytes; Melanosis; Prostaglandins F, Synthetic	2004
Species differences in the effects of prostanoids on MAP kinase phosphorylation, myosin light chain phosphorylation and contraction in bovine and cat iris sphincter smooth muscle. Prostaglandins, leukotrienes, and essential fatty acids, 2005, Volume: 72, Issue:1 Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Cats; Cattle; Dinoprost; Dinoprostone; Extracellular Signal-Regulated MAP Kinases; Iris; Latanoprost; Muscle Contraction; Muscle, Smooth; Myosin Light Chains; Phosphorylation; Prostaglandins; Prostaglandins F, Synthetic; Species Specificity	2005
[Adverse reaction after use of latanoprost in Japanese glaucoma patients]. Nippon Ganka Gakkai zasshi, 2006, Volume: 110, Issue:8 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Eyelashes; Eyelids; Female; Glaucoma; Humans; Iris; Latanoprost; Male; Middle Aged; Pigmentation Disorders; Prospective Studies; Prostaglandins F, Synthetic	2006
Prostaglandin F2alpha, but not latanoprost, increases the Ca2+ sensitivity of the pig iris sphincter muscle. Investigative ophthalmology & visual science, 2006, Volume: 47, Issue:11 Topics: Animals; Antihypertensive Agents; Calcium; Carbachol; Dinoprost; Enzyme Inhibitors; Intracellular Signaling Peptides and Proteins; Iris; Latanoprost; Muscle Contraction; Muscle, Smooth; Myosin Light Chains; Phosphorylation; Prostaglandins F, Synthetic; Protein Serine-Threonine Kinases; rho-Associated Kinases; Swine; Type C Phospholipases	2006
Morphometric effects of long-term exposure to latanoprost. Ophthalmology, 2007, Volume: 114, Issue:5 Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Eye Color; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Iridectomy; Iris; Iris Diseases; Latanoprost; Male; Melanins; Melanocytes; Middle Aged; Pigmentation Disorders; Prostaglandins F, Synthetic	2007
Monte Carlo simulation of latanoprost induced iris darkening. Computer methods and programs in biomedicine, 2007, Volume: 87, Issue:2 Topics: Antihypertensive Agents; Computer Simulation; Dose-Response Relationship, Drug; Eye Color; Humans; Iris; Iris Diseases; Latanoprost; Melanins; Models, Biological; Monte Carlo Method; Pigmentation Disorders; Prostaglandins F, Synthetic	2007
Iris morphology. Ophthalmology, 2008, Volume: 115, Issue:2 Topics: Antihypertensive Agents; Eye Color; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Iridectomy; Iris; Iris Diseases; Latanoprost; Melanins; Melanocytes; Pigmentation Disorders; Prostaglandins F, Synthetic	2008
A study of histopathological features of latanoprost-treated irides with or without darkening compared with non-latanoprost-treated irides. Archives of ophthalmology (Chicago, Ill. : 1960), 2008, Volume: 126, Issue:5 Topics: Antihypertensive Agents; Endothelium, Vascular; Fibroblasts; Glaucoma; Humans; Iridectomy; Iris; Iris Diseases; Latanoprost; Melanins; Melanocytes; Melanosis; Prostaglandins F, Synthetic	2008
Latanoprost-induced changes in the iris and trabeculum: an electron-microscopic morphological study. International ophthalmology, 2010, Volume: 30, Issue:1 Topics: Aged; Antihypertensive Agents; Exfoliation Syndrome; Glaucoma, Open-Angle; Humans; Iridectomy; Iris; Latanoprost; Male; Melanins; Microscopy, Electron, Transmission; Middle Aged; Prostaglandins F, Synthetic; Time Factors; Trabecular Meshwork; Trabeculectomy	2010
Ocular hypotensive activity of BOL-303259-X, a nitric oxide donating prostaglandin F2α agonist, in preclinical models. Experimental eye research, 2011, Volume: 93, Issue:3 Topics: Administration, Topical; Animals; Antihypertensive Agents; Aqueous Humor; Cell Line; Ciliary Body; Cyclic GMP; Dinoprost; Disease Models, Animal; Dogs; Drug Evaluation, Preclinical; Female; Glaucoma; Guanylate Cyclase; Intraocular Pressure; Iris; Latanoprost; Macaca fascicularis; Male; Nitric Oxide; Nitric Oxide Donors; Ocular Hypertension; Prostaglandins F, Synthetic; Rabbits; Rats; Tonometry, Ocular	2011
Effects of sustained daily latanoprost application on anterior chamber anatomy and physiology in mice. Scientific reports, 2018, 08-30, Volume: 8, Issue:1 Topics: Animals; Anterior Chamber; Benzalkonium Compounds; Cornea; Delayed-Action Preparations; Intraocular Pressure; Iris; Latanoprost; Male; Matrix Metalloproteinases; Mice, Inbred C57BL; Pigmentation; Time Factors	2018
Novel mechanism of decreased iris vasculature density after cosmetic iris implants. BMJ case reports, 2021, Feb-04, Volume: 14, Issue:2 Topics: Acetaminophen; Acetazolamide; Administration, Intravenous; Adult; Analgesics, Non-Narcotic; Carbonic Anhydrase Inhibitors; Humans; Intraocular Pressure; Iris; Iris Diseases; Latanoprost; Male; Mydriasis; Ophthalmic Solutions; Prostheses and Implants; Tomography, Optical Coherence	2021